scholarly article | Q13442814 |
P2093 | author name string | H A Jinnah | |
Ellen J Hess | |||
Xueliang Fan | |||
Chang-Hyun Song | |||
Cicely J Exeter | |||
P2860 | cites work | The basal ganglia and cerebellum interact in the expression of dystonic movement | Q24653882 |
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease | Q28510609 | ||
Immunocytochemical characterization of torsin proteins in mouse brain | Q28511582 | ||
Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope | Q28589351 | ||
Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome | Q28589709 | ||
Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome | Q28591144 | ||
Rodent models for dystonia research: characteristics, evaluation, and utility | Q33210715 | ||
Abnormal structure-function relationships in hereditary dystonia | Q33402008 | ||
Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice. | Q33723034 | ||
Altered dendritic morphology of Purkinje cells in Dyt1 ΔGAG knock-in and purkinje cell-specific Dyt1 conditional knockout mice. | Q33867544 | ||
Immunohistochemical localization and distribution of torsinA in normal human and rat brain | Q33886989 | ||
Cellular distribution of torsin A and torsin B in normal human brain | Q33951281 | ||
Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice | Q34023627 | ||
Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease | Q34117291 | ||
Expression of the early-onset torsion dystonia gene (DYT1) in human brain. | Q34467898 | ||
Dystonia in Parkinson's disease | Q34585274 | ||
Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. | Q34836384 | ||
Commentary: Dopaminergic dysfunction in DYT1 dystonia | Q35009095 | ||
The DYT1 carrier state increases energy demand in the olivocerebellar network | Q35210345 | ||
Dysfunction of dopaminergic pathways in dystonia | Q35543720 | ||
An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice | Q35576523 | ||
Motor deficits and hyperactivity in Dyt1 knockdown mice. | Q35629540 | ||
D2-like dopamine receptors mediate the response to amphetamine in a mouse model of ADHD. | Q35809256 | ||
Improved motor performance in Dyt1 ΔGAG heterozygous knock-in mice by cerebellar Purkinje-cell specific Dyt1 conditional knocking-out | Q35878028 | ||
Basal ganglia dopamine loss due to defect in purine recycling | Q35908559 | ||
The functional neuroanatomy of dystonia | Q36340491 | ||
Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice | Q36666604 | ||
TorsinA and dystonia: from nuclear envelope to synapse. | Q37490209 | ||
Primary dystonia: molecules and mechanisms. | Q37614200 | ||
Concept and classification of dystonia | Q39512463 | ||
Functional and molecular differentiation of the dopamine system induced by neonatal denervation | Q41176113 | ||
Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain | Q42479695 | ||
Dopamine release is impaired in a mouse model of DYT1 dystonia | Q42513622 | ||
Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. | Q42590497 | ||
Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo | Q42593925 | ||
Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. | Q42658331 | ||
Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia | Q42671584 | ||
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia | Q42813363 | ||
The midbrain dopaminergic system: anatomy and genetic variation in dopamine neuron number of inbred mouse strains | Q43723860 | ||
The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod | Q44169382 | ||
Dopamine transmission in DYT1 dystonia | Q44596265 | ||
Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia. | Q44804036 | ||
Ethanol's effects on gait dynamics in mice investigated by ventral plane videography | Q45193992 | ||
Transgenic mouse model of early-onset DYT1 dystonia | Q46232270 | ||
The metabolic pathology of dopa-responsive dystonia | Q46399764 | ||
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia. | Q46798860 | ||
Motor deficits and hyperactivity in cerebral cortex-specific Dyt1 conditional knockout mice | Q46935059 | ||
Age-dependent neurobehavioral plasticity following forebrain dopamine depletions | Q47738132 | ||
Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities. | Q48120915 | ||
TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion | Q48378126 | ||
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia. | Q48436385 | ||
The motor phenotype of Parkinson's disease in relation to age at onset | Q50266093 | ||
Developmental expression of rat torsinA transcript and protein. | Q52088364 | ||
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. | Q52278152 | ||
Dystonia. | Q55042366 | ||
Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome | Q80383562 | ||
P433 | issue | 1 | |
P921 | main subject | dopamine | Q170304 |
P304 | page(s) | 66-78 | |
P577 | publication date | 2012-05-31 | |
P1433 | published in | Neurobiology of Disease | Q15716606 |
P1476 | title | Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia | |
P478 | volume | 48 |
Q36232197 | A new knock-in mouse model of l-DOPA-responsive dystonia |
Q30441885 | Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. |
Q36591812 | Abnormalities of motor function, transcription and cerebellar structure in mouse models of THAP1 dystonia. |
Q35836503 | Analysis of gait in rats with olivocerebellar lesions and ability of the nicotinic acetylcholine receptor agonist varenicline to attenuate impairments |
Q37058173 | Animal models for dystonia |
Q47623854 | Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease |
Q90747980 | Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice |
Q92000933 | Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia |
Q48531888 | Dopamine receptor agonist treatment for idiopathic dystonia: A reappraisal in humans and mice |
Q37592345 | Dystonia as a network disorder: what is the role of the cerebellum? |
Q89633692 | Dystonia: Sparse Synapses for D2 Receptors in Striatum of a DYT1 Knock-out Mouse Model |
Q47585471 | Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels. |
Q42755733 | Electromyographic evidence in support of a knock-in mouse model of DYT1 Dystonia |
Q38124786 | Emerging common molecular pathways for primary dystonia. |
Q37239952 | Engineering animal models of dystonia |
Q33790163 | Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia. |
Q91676683 | Freezing of Gait can persist after an acute levodopa challenge in Parkinson's disease |
Q48433008 | Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain. |
Q89595744 | Increased endogenous dopamine prevents myopia in mice |
Q33919548 | Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo |
Q64786603 | Loss of the dystonia gene Thap1 leads to transcriptional deficits that converge on common pathogenic pathways in dystonic syndromes |
Q35049257 | Minimal Change in the cytoplasmic calcium dynamics in striatal GABAergic neurons of a DYT1 dystonia knock-in mouse model |
Q39779374 | Motor phenotypes and molecular networks associated with germline deficiency of Ciz1. |
Q36605114 | Neuropathology of cervical dystonia |
Q48585249 | Parkinsonism without dopamine neuron degeneration in aged l-dopa-responsive dystonia knockin mice |
Q61809637 | Retracted: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes |
Q89675943 | Short-Wavelength (Violet) Light Protects Mice From Myopia Through Cone Signaling |
Q28648007 | Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia |
Q37383467 | Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp |
Q37424519 | Subtle microstructural changes of the cerebellum in a knock-in mouse model of DYT1 dystonia |
Q36774120 | Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia |
Q46481280 | The Anatomical Basis for Dystonia: The Motor Network Model |
Q37070290 | The focal dystonias: current views and challenges for future research |
Q38115272 | The genetics of dystonia: new twists in an old tale |
Q33841496 | The relationship between the dopaminergic system and depressive symptoms in cervical dystonia |
Q36331007 | The ubiquitin ligase F-box/G-domain protein 1 promotes the degradation of the disease-linked protein torsinA through the ubiquitin-proteasome pathway and macroautophagy. |
Q38176494 | The vesicular monoamine transporter 2: an underexplored pharmacological target |
Q37444067 | Understanding the anatomy of dystonia: determinants of penetrance and phenotype |
Search more.